BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease

N Engl J Med. 2024 Sep 5;391(9):867-869. doi: 10.1056/NEJMc2408786.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Bispecific / administration & dosage
  • Autoimmune Diseases* / drug therapy
  • Autoimmune Diseases* / immunology
  • B-Cell Maturation Antigen* / antagonists & inhibitors
  • B-Cell Maturation Antigen* / immunology
  • Female
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Immunosuppressive Agents* / adverse effects
  • Middle Aged
  • T-Lymphocytes* / drug effects
  • T-Lymphocytes* / immunology
  • Treatment Outcome

Substances

  • B-Cell Maturation Antigen
  • Antibodies, Bispecific
  • Immunosuppressive Agents